Clinical connections: Assays and assessment

Lupus

Volumn 6, Issue 3, 1997, Pages 305-306

  Bell, D A ^a   Smeenk, R J T ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Division of Diagnostic Services   (Netherlands)

Author keywords

Auto antibodies; SLE; Utility

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY;

CONFERENCE PAPER; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030892845     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600317     Document Type: Conference Paper

References (15)

1. Smeenk RJT. Measurement of antibodies to DNA. In: Venrooij W, Mami RN: (eds). Manual of Biological Markers of Disease. Kluwer Academic Publishers: Dordrecht/Boston/London, 1993, A8/1-A8/12.
2. Feltkamp TEW et al. The first international standard to antibodies to dsDNA. Ann Rheum Dis 1988; 47: 740-746.
3. Emlen W, Jarusiripipat P, Burdick G. A new ELISA for the detection of double-stranded DNA antibodies. J Immunol Methods 1990; 132: 91-101.
4. Hylkema MN et al. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J Immunol Methods 1994; 70: 93-102.
5. Swaak AJG, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non Systemic Lupus Erythematosus (SLE) patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985; 44: 245-251.
6. Swaak AJG et al. Anti-ds DNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 1979; 22. 226-235.
7. Swaak AJG et al. Prognostic value of anti-ds DNA in SLE. Ann Rheum Dis 1982; 41: 388-395.
8. Bootsma H et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345: 1595-1599.
9. Swaak AJG, Smeenk R. Clinical differences between SLE patients in relation to the avidity of their anti-dsDNA. In: Peeters H (ed). Protides of the Biological Fluids. Pergamon Press: London, 1985, pp 317-320.
10. Smeenk R, Rooyen Avan, Swaak AJG Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity. J Immunol Methods 1988; 109: 27-35.
11. Worrall J et al. SLEa rheumatological view. Quart J Med 1990, 275: 319-330.
12. McCarthy GA, Harley JB, Reichlin M. A distinctive autoantibody profile in black female patients with lupus nephritis. Arth Rheum 1993; 36: 1560-1565.
13. Hay EM et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus Quart J Med 1993; 86: 447-458.
14. Gladman D et al. Sensitivity to change on 3 systemic lupus disease activity indices: international validation. J Rheum 1994; 21: 1468-1471.
15. Joseph A et al. Absence of a distinctive autoantibody profile in black women with lupus nephntisArth Rheum 1994; 8: 1261-1264.